CF

Christine Favre

IS Ipsen Pharma S.A.S.: 5 patents #15 of 146Top 15%
IL Ipsen Biopharm Limited: 1 patents #30 of 71Top 45%
📍 Arpajon, FR: #19 of 190 inventorsTop 10%
Overall (All Time): #796,033 of 4,157,543Top 20%
6
Patents All Time

Issued Patents All Time

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
11975055 Suppression of bone cancer-induced allodynia Mikhail KALINICHEV 2024-05-07
9259458 Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy Michel Auguet, Piere-Etienne Chabrier De Lassauniere 2016-02-16
9080220 Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative Michel Auguet, Pierre-Etienne Chabrier de Lassauniere 2015-07-14
8921322 Use of at least one botulinum neurotoxin for treating the pain induced by therapeutic treatments for the AIDS virus Michel Auguet, Pierre-Etienne Chabrier de Lassauniere 2014-12-30
8784841 Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy Michel Auguet, Piere-Etienne Chabrier De Lassauniere 2014-07-22
8273359 Therapeutic use of at least one botulinum neurotoxin in the treatment of pain induced by at least one anti-neoplastic agent Michel Auguet, Pierre-Etienne Chabrier de Lassauniere 2012-09-25